Low Back Pain
Conditions
Keywords
laser, LLLT, back pain, pain, low back pain
Brief summary
The purpose of this research study is to gather information on the effectiveness of the Trident low-level laser therapy (LLLT) in combination with clinical patient education manuals to reduce lower back pain.
Detailed description
Patients will be administered one of 4 treatment options using the Trident LLLT. The treatment options include 2 treatments, 4 treatments, 6 treatments or 8 treatments. All patients will receive two self-help patient education manuals. Low Back Pain will be compared among all 4 options at the end of week 6.
Interventions
DEVICEErchonia® Trident
Low-level laser therapy
Sponsors
Mayo Clinic
Erchonia Corporation
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
All patients will self-select one of four treatment options: 1 week (2 treatment), 2 weeks (4 treatments), 3 weeks (6 treatments) and 4 weeks (8 treatments).
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Reporting a primary pain point in lower back. * Pain intensity reported at baseline must be 4 and above on the Visual Analogue scale (PROMIS Numeric Rating Scale). * Individual able to participate fully in all aspects of the study and have understood and signed study informed consent.
Exclusion criteria
* Have used pain medications or participated in a pain treatment within three days of study enrollment. * Have an implanted device (including lap band) in the targeted area of Low Level Laser Treatment. * Have used an investigational drug within 30 days of study enrollment. * Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the low level laser treatment phase and are unwilling to use a reliable form of contraception. Acceptable forms of contraception include: Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants; Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm); Intrauterine device (IUD); Total hysterectomy or tubal ligation; Abstinence (no sex). * Have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease. * Have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled diabetes type 2), active cancer, actively receiving l treatment for cancer or within 1 year of cancer remission. * Surgical intervention for pain within 1 month prior to enrollment. * Active infection, wound or other external trauma to the areas to be treated with the laser * Known photosensitivity disorder. * Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Brief Pain Inventory score | Baseline, Week 6 | The PROMIS Numeric Rating Scale v1.0 - Pain Intensity 1a will be used to measure pain intensity on a VAS scale where '0' is no pain and '10' being the worst imaginable pain. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORIvana T Croghan, PhD
Mayo Clinic
PRINCIPAL_INVESTIGATORRyan T Hurt, MD, PhD
Mayo Clinic
Outcome results
None listed